Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications (Q34677262)

3 August 2017

1 reference

title

Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications (English)

1 reference

3 August 2017

1 reference

4

George P Chrousos

1 reference

3 August 2017

Philip W Gold

1

1 reference

3 August 2017

K Eddie Gabry

series ordinal

2

1 reference

3 August 2017

Mariko R Yasuda

series ordinal

3

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

Endocrinology and Metabolism Clinics of North America

3 August 2017

published in

1 reference

3 August 2017

volume

31

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

37-62, vi

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Natural history and preventative treatment of recurrent mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Suicide and Primary Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Minor and major depression and the risk of death in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Bone mineral density in women with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Stressful life events, genetic liability, and onset of an episode of major depression in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The lifetime history of major depression in women. Reliability of diagnosis and heritability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Reversed neurovegetative symptoms of depression: a community study of Ontario.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The validity of major depression with atypical features based on a community study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Mechanisms of emotional arousal and lasting declarative memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Through the looking glass: differential noradenergic modulation of prefrontal cortical function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Influence of Corticotropin-Releasing Factor on Reproductive Functions in the Rat*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Effects of corticotropin releasing hormone on appetitive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Indelibility of subcortical emotional memories.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Storage and executive processes in the frontal lobes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Extinction of emotional learning: contribution of medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The catecholamine hypothesis of affective disorders: a review of supporting evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Transient Depressive Relapse Induced by Catecholamine Depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Effect of ganglion blockade on cerebrospinal fluid norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Indices of noradrenergic output in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Cerebrospinal fluid adrenaline and noradrenaline in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

3-Methoxy-4-hydroxyphenylglycol in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The peripheral kinetics of norepinephrine in depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

High plasma norepinephrine levels in patients with major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Resting Plasma Catecholamine Concentrations in Patients With Depression and Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Depressive symptom patterns and urinary MHPG excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

MHPG excretion in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Role of biogenic amines in certain pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Changes in regional cerebral blood flow on recovery from depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Blood flow changes in human somatosensory cortex during anticipated stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

The cytokine-HPA axis feed-back circuit

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900022-6

7 January 2021

10.1016/S0889-8529(01)00022-6

Identifiers

DOI

1 reference

3 August 2017

1 reference